These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11033338)

  • 41. A putative model of the dopamine transporter.
    Edvardsen O; Dahl SG
    Brain Res Mol Brain Res; 1994 Dec; 27(2):265-74. PubMed ID: 7898310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RTI-352: a 3 alpha analogue of RTI-55 as an in vivo dopamine transporter binding ligand.
    Zhan Y; Saindane AM; Scheffel U; Carroll FI; Holmquist CR; Kepler JA; Taylor GF; Kuhar MJ
    Synapse; 1997 Apr; 25(4):389-92. PubMed ID: 9097398
    [No Abstract]   [Full Text] [Related]  

  • 43. [3H]WIN 35,428 binding in the caudate nucleus of the rabbit: evidence for a single site on the dopamine transporter.
    Aloyo VJ; Ruffin JS; Pazdalski PS; Kirifides AL; Harvey JA
    J Pharmacol Exp Ther; 1995 Apr; 273(1):435-44. PubMed ID: 7714799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants.
    Buck KJ; Amara SG
    Mol Pharmacol; 1995 Dec; 48(6):1030-7. PubMed ID: 8848002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The top 20 dopamine transporter mutants: structure-function relationships and cocaine actions.
    Uhl GR; Lin Z
    Eur J Pharmacol; 2003 Oct; 479(1-3):71-82. PubMed ID: 14612139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The region of dopamine transporter encompassing the 3rd transmembrane domain is crucial for function.
    Lee SH; Kang SS; Son H; Lee YS
    Biochem Biophys Res Commun; 1998 May; 246(2):347-52. PubMed ID: 9610361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
    Héron C; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1994 Nov; 264(3):391-8. PubMed ID: 7698180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims.
    Staley JK; Hearn WL; Ruttenber AJ; Wetli CV; Mash DC
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1678-85. PubMed ID: 7996484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Which form of dopamine is the substrate for the human dopamine transporter: the cationic or the uncharged species?
    Berfield JL; Wang LC; Reith ME
    J Biol Chem; 1999 Feb; 274(8):4876-82. PubMed ID: 9988729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton.
    Kozikowski AP; Araldi GL; Boja J; Meil WM; Johnson KM; Flippen-Anderson JL; George C; Saiah E
    J Med Chem; 1998 May; 41(11):1962-9. PubMed ID: 9599245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopamine transporter.
    Lee SH; Chang MY; Lee KH; Park BS; Lee YS; Chin HR; Lee YS
    Mol Pharmacol; 2000 May; 57(5):883-9. PubMed ID: 10779370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and ligand binding studies of 4'-iodobenzoyl esters of tropanes and piperidines at the dopamine transporter.
    Singh S; Basmadjian GP; Avor KS; Pouw B; Seale TW
    J Med Chem; 1997 Aug; 40(16):2474-81. PubMed ID: 9258354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors.
    Izenwasser S; Terry P; Heller B; Witkin JM; Katz JL
    Eur J Pharmacol; 1994 Oct; 263(3):277-83. PubMed ID: 7843265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA.
    Shimada S; Kitayama S; Lin CL; Patel A; Nanthakumar E; Gregor P; Kuhar M; Uhl G
    Science; 1991 Oct; 254(5031):576-8. PubMed ID: 1948034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
    Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
    Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.
    Houlihan WJ; Boja JW; Parrino VA; Kopajtic TA; Kuhar MJ
    J Med Chem; 1996 Dec; 39(25):4935-41. PubMed ID: 8960553
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defining proximity relationships in the tertiary structure of the dopamine transporter. Identification of a conserved glutamic acid as a third coordinate in the endogenous Zn(2+)-binding site.
    Loland CJ; Norregaard L; Gether U
    J Biol Chem; 1999 Dec; 274(52):36928-34. PubMed ID: 10601246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Probing structure of neurotransmitter transporters by substituted-cysteine accessibility method.
    Javitch JA
    Methods Enzymol; 1998; 296():331-46. PubMed ID: 9779459
    [No Abstract]   [Full Text] [Related]  

  • 59. Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands.
    Gulley JM; Zahniser NR
    Eur J Pharmacol; 2003 Oct; 479(1-3):139-52. PubMed ID: 14612145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positron emission tomography studies of dopamine-enhancing drugs.
    Fowler JS; Volkow ND; Ding YS; Wang GJ; Dewey S; Fischman MW; Foltin R; Hitzemann R
    J Clin Pharmacol; 1999 Aug; 39(S1):13S-16S. PubMed ID: 10434242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.